These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 19114981

  • 21. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K, Neumann H, Fry LC, Kolfenbach S, Malfertheiner P.
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [Abstract] [Full Text] [Related]

  • 22. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM, Fitzgerald JF, Molleston JP, Gupta SK, Corkins MR, Pfefferkorn MD, Lim JR, Steiner SJ, Dadzie SK.
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [Abstract] [Full Text] [Related]

  • 23. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trial.
    Wong WM, Bautista J, Dekel R, Malagon IB, Tuchinsky I, Green C, Dickman R, Esquivel R, Fass R.
    Aliment Pharmacol Ther; 2005 Jan 15; 21(2):155-63. PubMed ID: 15679765
    [Abstract] [Full Text] [Related]

  • 24. Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.
    Ayazi S, Lipham JC, Portale G, Peyre CG, Streets CG, Leers JM, Demeester SR, Banki F, Chan LS, Hagen JA, Demeester TR.
    Clin Gastroenterol Hepatol; 2009 Jan 15; 7(1):60-7. PubMed ID: 18976965
    [Abstract] [Full Text] [Related]

  • 25. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
    Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M.
    Am J Gastroenterol; 2007 Dec 15; 102(12):2642-7. PubMed ID: 17850412
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
    Kahrilas PJ, Pandolfino JE.
    Aliment Pharmacol Ther; 2005 Dec 15; 22 Suppl 3():2-9. PubMed ID: 16303031
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure.
    Pandolfino JE, Schreiner MA, Lee TJ, Zhang Q, Boniquit C, Kahrilas PJ.
    Am J Gastroenterol; 2005 Jul 15; 100(7):1466-76. PubMed ID: 15984967
    [Abstract] [Full Text] [Related]

  • 29. The role of pH monitoring in extraesophageal gastroesophageal reflux disease.
    Ahmed T, Vaezi MF.
    Gastrointest Endosc Clin N Am; 2005 Apr 15; 15(2):319-31. PubMed ID: 15722244
    [Abstract] [Full Text] [Related]

  • 30. Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects.
    Gardner JD, Sloan S, Robinson M, Miner PB.
    Aliment Pharmacol Ther; 2004 Dec 15; 20(11-12):1373-9. PubMed ID: 15606400
    [Abstract] [Full Text] [Related]

  • 31. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance.
    Yamaguchi T, Seza A, Odaka T, Shishido T, Ai M, Gen S, Kouzu T, Saisho H.
    Gastrointest Endosc; 2006 Jun 15; 63(7):1046-50. PubMed ID: 16733123
    [Abstract] [Full Text] [Related]

  • 32. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
    Marchese M, Spada C, Iacopini F, Familiari P, Shah SG, Tringali A, Costamagna G.
    Endoscopy; 2006 Aug 15; 38(8):813-8. PubMed ID: 17001571
    [Abstract] [Full Text] [Related]

  • 33. Wireless pH capsule--yield in clinical practice.
    Roman S, Mion F, Zerbib F, Benamouzig R, Letard JC, Bruley des Varannes S.
    Endoscopy; 2012 Mar 15; 44(3):270-6. PubMed ID: 22275050
    [Abstract] [Full Text] [Related]

  • 34. [Prolonged esophageal pH monitoring].
    Cecconello I.
    Arq Gastroenterol; 1997 Mar 15; 34(2):69-70. PubMed ID: 9496420
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Bravo pH capsule system.
    Kwiatek MA, Pandolfino JE.
    Dig Liver Dis; 2008 Mar 15; 40(3):156-60. PubMed ID: 18096447
    [Abstract] [Full Text] [Related]

  • 37. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
    Pandolfino JE, Lee TJ, Schreiner MA, Zhang Q, Roth MP, Kahrilas PJ.
    Dis Esophagus; 2006 Mar 15; 19(3):177-82. PubMed ID: 16722995
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Findings of 24-hour esophageal pH monitoring in patients with respiratory and otorhinolaryngologic manifestations of gastroesophageal reflux disease].
    Karoui S, Zouiten L, Matri S, Boubaker J, Filali A.
    Tunis Med; 2006 Mar 15; 84(3):165-9. PubMed ID: 16755957
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.